An adjuvanted water in oil emulsion vaccine for injection, consisting of an inactivated culture of Salmon Pancreas Disease Virus (SPDV) strain AL V405 RPSend ≥ 80% together with liquid paraffin as an adjuvant.

For the active immunisation of Atlantic salmon to reduce mortality, lesions in the heart and pancreas, and impaired growth caused by Pancreas Disease (PD). Onset of immunity occurs no later than 516 degree days after vaccination. The vaccine reduces mortality, lesions in the heart and pancreas and impaired growth caused by SPDV infection for up to 12 months after vaccination.

The recommended dose is 0.05 ml per fish. The vaccine will be administered by intraperitoneal (i.p) injection. The fish should be anaesthetised prior to injection. It is recommended to starve the fish for a minimum of 48 hours before vaccination.

The vaccine should be left to slowly reach 15-20°C by keeping it at room temperature. The vaccine should not be used if the vaccine shows signs of a brownish water phase in the bottom of the container. Contact the distributor for further advice. The vaccine should be well shaken prior to use by squeezing and shaking for approx. 2 minutes. Only administer if the vaccine appears as a homogenous, white to cream coloured emulsion.

To reduce the risk of adverse reactions, it is important to deposit the entire dose into the abdominal cavity. The injection needle used should have appropriate length to penetrate the abdominal wall by 1-2 mm. The entire needle should be inserted into the midline about one fin length anterior to the base of the pelvic fin.

The injection devices used for vaccination, i.e. automatic vaccination machines or manual syringes, must be designed and suitable for administration of the recommended dose volume in the target species. The devices must be operated by trained personnel and should be calibrated according to the manufacturers´ recommendation prior to use. Special care should be taken to ensure air is removed from the injection equipment (chambers and tubes) prior to vaccination. Regular dose controls (number of injections per bag) are recommended.

Vaccination of broodfish is not recommended and should be subject to a risk benefit evaluation of the prescribing veterinarian/fish health biologist.

Fish with clinical symptoms of disease should not be vaccinated. Vaccination should preferably be performed at water temperatures of 15°C or lower. Avoid vaccination during smoltification.

Safety and efficacy data are available which demonstrate that this vaccine can be administered simultaneously with PHARMAQ's oil adjuvanted multivalent vaccines containing the following antigens: Aeromonas salmonicida, Listonella anguillarum O1 and O2a, Vibrio salmonicida, Moritella viscosa and Infectious Pancreas Necrosis Virus (IPNV). The vaccines are administered intraperitoneally either simultaneously (one injection) or in immediate succession (two injections) while fish are anaesthetised.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Do not mix with any other veterinary medicinal products.

Melanisation and vaccine residues are very commonly observed in the abdominal cavity after vaccination. Mild visceral adhesions (corresponding to Speilberg scores 1 – 2) are very common, moderate adhesions (corresponding to Speilberg score 3) are common, while the occurrence of severe adhesions (corresponding to Speilberg scores ≥ 4) are very rare. The same frequencies for visceral adhesions are observed both in fresh water and in sea water.

The frequency of adverse reactions is defined using the following convention:

Administration of a double dose of vaccine (0.1 ml) shows no other adverse reactions than those described in above.

Zero degree days.

The use of needle guards is recommended in order to reduce the risk of accidental self-injection.

To the user: This veterinary medicinal product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.

If you are accidentally injected with this veterinary medicinal product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.

To the physician: This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.

Store and transport refrigerated (2°C - 8°C). Do not freeze. Protect from light.

Shelf-life after first opening the immediate packaging: 10 hours.

Keep out of the sight and reach of children.

For animal treatment only.

Injection bags containing 250 ml or 500 ml.

Not all pack sizes may be marketed.

Pharmaq AS

Skogmo Industriområde

Industrivegen 50

7863 Overhalla

Norway

Stimulates development of active immunity against Pancreas Disease. Reduction of mortality during clinical outbreaks of Pancreas Disease has been documented up to 15 months post vaccination under field conditions.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

UK (GB): Vm 21714/4005

UK (NI): Vm 21714/4005